Who Owns ANI Pharmaceuticals Stock?
NASDAQ: ANIPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 107.29%
- Institutions (% of float)
- 113.43%
- Held by insiders
- 5.42%
- Institutional holders
- 418
- Institutions 94.6%
- Insiders 5.4%
- Public and other 0.0%
Who owns ANI Pharmaceuticals stock?
Institutional investors own about 107.3% of ANI Pharmaceuticals's shares, spread across 418 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 5.42% of ANIP.
The largest institutional holders are Blackrock Inc. (12.89%), Soleus Capital Management, L.P. (3.78%) and Vanguard Capital Management LLC (3.65%). Together, the top 10 institutions control 39.5% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their ANIP positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ANIP
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 2.96M | 12.89% | +7.7% |
| Soleus Capital Management, L.P. | 867.76K | 3.78% | +5.8% |
| Vanguard Capital Management LLC | 838.22K | 3.65% | +1.8% |
| State Street Corporation | 831.65K | 3.62% | +7.8% |
| Tang Capital Management, LLC | 707.50K | 3.08% | 0.0% |
| Dimensional Fund Advisors LP | 623.46K | 2.72% | +17.4% |
| American Century Companies Inc | 574.47K | 2.50% | +199.9% |
| Arrowstreet Capital, Limited Partnership | 562.02K | 2.45% | -0.4% |
| Global Alpha Capital Management Ltd. | 558.00K | 2.43% | +54.5% |
| Geode Capital Management, LLC | 536.41K | 2.34% | +9.7% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ANIP
| Fund | Shares | % Held |
|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 1.11M | 4.84% |
| American Century ETF Trust-Avantis U.S. Small Cap Value ETF | 660.69K | 2.88% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 609.43K | 2.65% |
| iShares Trust-iShares Russell 2000 ETF | 519.52K | 2.26% |
| OBERWEIS FUNDS-Oberweis Micro-Cap Fund | 256.30K | 1.12% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 224.19K | 0.98% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 209.10K | 0.91% |
| College Retirement Equities Fd.-College Retirement Equities Fd. - Tota | 204.47K | 0.89% |
| IVY FUNDS-Nomura Small Cap Growth Fund | 195.00K | 0.85% |
| iShares Trust-iShares Russell 2000 Growth ETF | 191.12K | 0.83% |
Frequently asked questions
Who is the largest shareholder of ANI Pharmaceuticals?
Blackrock Inc. is the largest institutional shareholder of ANIP, owning 12.89% of shares outstanding (2.96M shares) as of its latest 13F filing.
What percentage of ANI Pharmaceuticals is owned by institutions?
Institutions own about 107.3% of ANIP shares and 113.4% of the public float.
How much of ANI Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 5.42% of ANIP shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.